MICIS has recently expanded its offerings to include a new educational module on the latest evidence concerning anti-platelet therapies. The module covers the risks, benefits, and indications for a range of anti-platelet therapies and answers common questions, such as when is Plavix preferred over aspirin and when is it not.

Practitioners interested in receiving an educational visit by a trained clinician in the convenience of their own office may contact Kellie Miller at the Maine Medical Association at 207-622-3374, ext. 229 or kmiller@mainemed.com.

An Adult Type 2 Diabetes module is also available.